| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 35.240 | 111.512 | 209.915 | 314.678 | 361.986 | 393.648 |
| Total Income - EUR | - | - | - | - | 41.405 | 124.073 | 218.812 | 318.548 | 368.948 | 404.357 |
| Total Expenses - EUR | - | - | - | - | 38.854 | 104.771 | 164.197 | 224.838 | 244.493 | 321.563 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.550 | 19.302 | 54.615 | 93.711 | 124.456 | 82.795 |
| Net Profit/Loss - EUR | - | - | - | - | 2.143 | 18.351 | 52.647 | 90.784 | 121.453 | 72.732 |
| Employees | - | - | - | - | 4 | 5 | 6 | 8 | 10 | 11 |
Check the financial reports for the company - Pro Veterinaria Rx S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 31.281 | 51.898 | 51.738 | 51.776 | 50.140 | 139.509 |
| Current Assets | - | - | - | - | 33.398 | 35.851 | 56.769 | 90.310 | 149.629 | 165.239 |
| Inventories | - | - | - | - | 9.613 | 20.781 | 25.413 | 56.499 | 110.308 | 153.227 |
| Receivables | - | - | - | - | 1.432 | 771 | 8.730 | 11.923 | 27.593 | 6.121 |
| Cash | - | - | - | - | 22.352 | 14.299 | 22.626 | 21.887 | 11.728 | 5.890 |
| Shareholders Funds | - | - | - | - | 2.185 | 20.494 | 52.791 | 90.928 | 147.996 | 149.449 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 42.631 | 39.608 | 29.880 | 28.857 | 33.146 | 140.360 |
| Income in Advance | - | - | - | - | 33.823 | 30.110 | 25.837 | 22.301 | 18.628 | 14.938 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Pro Veterinaria Rx S.r.l.